window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 24, 2026

  • News
  • About Us
Contact Us

Movers & Shakers

  • Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    Jeremy Richardson joins Gifthealth as chief commercial officer to expand pharma partnerships

    Gifthealth has appointed Jeremy Richardson as its new chief commercial [...]

    January 19, 2026
  • Biotech,Clinical Development,Clinical studies,Clinical Trials,Healthcare leadership,Movers & Shakers,Rare Diseases

    Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth

    Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

    January 15, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    Will Edwards appointed CEO as Astoriom expands international storage and biorepository operations

    Astoriom, a global quality expert in safeguarding scientific research and [...]

    January 14, 2026
  • Biomanufacturing,Biotech,CDMOs & Manufacturing,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Symeres welcomes Jurgen Berendsen as CFO to support global expansion

    Symeres has appointed Jurgen Berendsen as chief financial officer, strengthening [...]

    January 14, 2026
  • Artificial Intelligence,Digital Health,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    CluePoints names Sinead Godkin CPO to scale global workforce

    CluePoints has appointed Sinead Godkin as chief people officer, strengthening [...]

    January 14, 2026
  • Biotech,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    BIA names Chris Molloy CEO to drive UK bioscience growth

    The BioIndustry Association (BIA) has appointed Chris Molloy as its [...]

    January 14, 2026
  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Clinical Development,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    iXCells names Steve Smith CEO to advance human iPSC preclinical services

    iXCells Biotechnologies has appointed Steve Smith as chief executive officer, [...]

    January 14, 2026
  • Clinical Development,Clinical Trials,Digital Health,Healthcare leadership,Movers & Shakers

    Qureight names Rebecca Simmons COO to lead operational scaling

    Qureight has appointed Rebecca Simmons as chief operating officer, strengthening [...]

    January 14, 2026
  • Biotech,Genetic Diseases,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics,Precision medicine

    Enhanced Genomics appoints Katerina Leftheris to board of directors

    Enhanced Genomics has appointed Katerina Leftheris to its board of [...]

    January 14, 2026
  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    NanoSyrinx appoints Thomas Farrell as CEO

    NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

    January 14, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study
    Categories: Uncategorised
  • Datwyler, LTS Device Technologies, and Stevanato Group collaborate on large-volume self-administration solutions
    Categories: Biologics & Biosimilars, Drug Delivery & Formulation, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
  • NeuroVice seizure oral injury device now available through BlinkRx
    Categories: Central Nervous System, Digital Health, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top